In addition, acetylation of K98, K117, K161, and K162 sites of p53 is quite important for its mediated iron death and oncogenic effects, and loss of acetylation of these four sites exhibited a severe defect in tumor growth inhibition and loss of regulation of the metabolic target SLC7A11 [90]. The gene discussed is TP53; the disease is neoplasm.